Kodiak Stock Gains 183% as New Eye Drugs Take Aim at Regeneron’s Eylea
Key Points:
- Users clicking the “Proceed” button will be redirected to a third-party website owned by Hong Kong Tiimoot Information Technology Co., Limited (HKT).
- The third-party website operates independently and is not controlled by Barron's.
- Barron's advises users to review HKT's Privacy Statement as it governs the privacy practices on the third-party site.
- Barron's disclaims responsibility for HKT's privacy or data-related practices.